Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print August 29, 2007, doi:10.1212/01.wnl.0000271883.45010.8a)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
01.wnl.0000271883.45010.8av1
69/17/1688    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, K. C.
Right arrow Articles by Ascherio, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, K. C.
Right arrow Articles by Ascherio, A.
Received February 28, 2007
Accepted May 16, 2007

Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease

Kelly Claire Simon SM*, Honglei Chen MD, PhD, Michael Schwarzschild MD, PhD, and Alberto Ascherio MD, DrPH

From the Departments of Epidemiology (K.C.S., A.A.) and Nutrition (A.A.), Harvard School of Public Health, Boston, MA; Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC (H.C.); Department of Neurology, Massachusetts General Hospital, Boston, MA (M.S.); and Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, MA (A.A.).


* To whom correspondence should be addressed. E-mail: ksimon{at}hsph.harvard.edu.

ABSTRACT

Objective: To determine whether history of hypertension, hypercholesterolemia, or diabetes is associated with risk of Parkinson disease (PD).

Methods: Prospective study among participants in two large cohorts: the Nurses’ Health Study (121,046 women) and the Health Professionals Follow-up Study (50,833 men). Mean duration of follow-up was 22.9 years in women, aged 30 to 55 years at baseline, and 12.6 years in men, aged 40 to 75 years at baseline. Relative risks (RRs) of PD were estimated from a Cox proportional hazards model adjusting for potential confounders.

Results: We identified a total of 530 incident cases of PD during the follow-up. Risk of PD was not associated with self-reported history of hypertension (RR = 0.96, 95% CI = 0.80 to 1.15), high cholesterol (RR = 0.98, 95% CI = 0.82 to 1.19), or diabetes (RR = 1.04, 95% CI = 0.74 to 1.46), after adjusting for age and smoking in pack-years. Risk of PD decreased modestly with increasing levels of self-reported total cholesterol (RR for a 50-mg/dL increase in total cholesterol = 0.86, 95% CI = 0.78 to 0.95, p for trend = 0.02), but use of cholesterol-lowering drugs was not associated with PD risk (RR comparing users with nonusers = 0.85, 95% CI = 0.59 to 1.23). Among individuals with PD, systolic blood pressure was similar to noncases up to the time of diagnosis but declined afterward.

Conclusions: Results of this large prospective study suggest that Parkinson disease risk is not significantly related to history of hypertension, hypercholesterolemia, or diabetes but may modestly decline with increasing blood cholesterol levels.




This article has been cited by other articles:


Home page
Diabetes CareHome page
J. A. Driver, A. Smith, J. E. Buring, J. M. Gaziano, T. Kurth, and G. Logroscino
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Diabetes Care, October 1, 2008; 31(10): 2003 - 2005.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Becker, G. P. Brobert, S. Johansson, S. S. Jick, and C. R. Meier
Diabetes in Patients With Idiopathic Parkinson's Disease
Diabetes Care, September 1, 2008; 31(9): 1808 - 1812.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Hu, R. Antikainen, P. Jousilahti, M. Kivipelto, and J. Tuomilehto
Total cholesterol and the risk of Parkinson disease
Neurology, May 20, 2008; 70(21): 1972 - 1979.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by AAN Enterprises, Inc.